ORINOVA
Besançon
About ORINOVA
Orinova develops targeted nanomedicines combining chemo-radiotherapy to treat solid tumors effectively.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Nov 2023)
Industries & Categories
Biotechnology, Nanotechnology, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/orinova-2766605 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.